Office Action Predictor
Last updated: April 15, 2026
Application No. 18/024,491

INORGANIC COMPOSITION ARTICLE

Final Rejection §102§103§112§DP
Filed
Mar 02, 2023
Examiner
COLGAN, LAUREN ROBINSON
Art Unit
1784
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Ohara INC.
OA Round
2 (Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
2y 7m
To Grant
75%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allow Rate
633 granted / 905 resolved
+4.9% vs TC avg
Moderate +5% lift
Without
With
+5.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
46 currently pending
Career history
951
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
44.7%
+4.7% vs TC avg
§102
23.3%
-16.7% vs TC avg
§112
18.4%
-21.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 905 resolved cases

Office Action

§102 §103 §112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Note that Applicant cannot rely upon the certified copy of the foreign priority application JP2020149312, and more specifically the filing date of said application, to overcome any rejection herein because a translation of said application has not been made of record in accordance with 37 CFR 1.55. When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate. See MPEP §§ 215 and 216. However, note that even with the filing of a translation, Ogasawara can still be applied as it names another invention and its priority date of March 6, 2019 precedes Applicants’ foreign priority date of September 4, 2020. Terminal Disclaimer The terminal disclaimer filed on November 11, 2025 disclaiming over US Patent No. 11,807,568 has been reviewed and is accepted. The terminal disclaimer has been recorded. Information Disclosure Statement The information disclosure statement (IDS) submitted on November 21, 2025 is being considered by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 3-7 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Specifically, claim 1, as well as claims 3-7 which depend therefrom, recite a content of Al2O3 being 10.75% or more but the specification as originally filed does not provide adequate support for the entirety of this range. In contrast, in reviewing the specification, every mention of Al2O3, the content limits are discussed as being 5% or more to less than 15% which not only does not support unlimited amounts of Al2O3 above 10.75% as is encompassed by the presently claimed open ended range but specifically does not encompass any values above 15%. Also, note for the record that Applicants’ comparative Example 1 which Applicants indicate as not in scope with their invention has an Al2O3 content of 18%. As such, it is clear that the scope of the invention as originally disclosed does not appear to encompass values of 15% or above let alone the unlimited entirety of the claimed range. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-7 is/are rejected under 35 U.S.C. 102(a1 and a2) as being anticipated by Ogasawara (WO2020179872, rejection using corresponding English document US11,807,568). Regarding claims 1-7: 568 teaches crystallized glass (inorganic composition article) containing an alpha cristobalite or alpha cristobalite solid solution as a main crystal phase (abstract) and comprises a composition meeting that claimed (see Examples 7-9, 11-15, 17-20, 21-24, 26-28 for instance). Regarding the claimed coloring degree and hardness properties, as shown above ‘568’s composition meets that of Applicants. Additionally, Applicants disclose that their article can be formed by the following 2-stage method (spec par 0036-0037). Temperature (oC) Duration (min) 1st stage 450-750, 500-720 or even 550-680 30-2000min or even 180-1440min 2nd stage 550-850 or even 600-800 30-600min or even 60-400min 568’ similarly discloses their article being formed by a 2-stage method shown below (see Col. 7, lines 4-14 and Examples 7-9, 11-15, 17-20, 21-24, 26-28). Temperature (oC) Duration (min) 1st stage 450-750, 500-720 or even 550-680 30-2000min or even 180-1440min 2nd stage 600-800 30-600min or even 60-400min Given the similarities, one skilled in the art would reasonably conclude the same properties to result (MPEP 2112). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Goto (USPub20080248316). Regarding claims 1-7: Goto teaches a crystallized glass (inorganic composition article) which can include alpha cristobalite solid solution as a main crystal phase (see Goto claim 2) and comprise the following in mass% (see Goto claims 9-10) overlapping with that claimed providing a prima facie case of obviousness (MPEP 2144.05). . SiO2 50-90 Li2O 4-15 Al2O3 2-20 ZrO2 0-10 K2O 0-3 P2O5 0-3 Na2O 0-2 MgO 0-3 CaO 0-7 SrO 0-7 BaO 0-7 ZnO 0-10 Sb2O3 0-2 TiO2 0-5 Note that Goto does not disclose the presence of B2O3, Nb2O5 or Ta2O5 which thereby corresponds to 0% of these oxides meeting the ranges of claims 2 and 6. Regarding the claimed coloring degree and hardness properties, as shown above Goto’s composition overlaps with Applicants. Additionally, Applicants disclose that their article can be formed by the following 2-stage method (spec par 0036-0037). Temperature (oC) Duration (min) 1st stage 450-750, 500-720 or even 550-680 30-2000min or even 180-1440min 2nd stage 550-850 or even 600-800 30-600min or even 60-400min Goto similarly discloses their article being formed by a 2-stage method shown below (0064, 0126). Temperature (oC) Duration (hr) 1st stage 450-620, or even 520-620 1-20hr (i.e. 60-1,200min) 2nd stage 620-800 0.5-10hrs (i.e. 30-600min) Given the similarities with the composition and method, one skilled in the art would reasonably conclude the same properties to result (MPEP 2112). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-7 of copending Application No. 18/994649 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-6 of copending Application No. 18/024490 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of copending Application No. 18/713168 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-11 of copending Application No. 18/834606 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-9 of copending Application No. 17/735055 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 of copending Application No. 19/114540 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-7 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 of copending Application No. 19/144511 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because they overlap in scope and any additional limitations would have been rendered obvious in view of the prior art above. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Response to Arguments Applicant’s arguments filed November 11, 2025 have been considered but are moot in view of new grounds of rejection. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAUREN ROBINSON COLGAN whose telephone number is (571)270-3474. The examiner can normally be reached Monday thru Friday 9AM to 5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Humera Sheikh can be reached at 571-272-0604. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. LAUREN ROBINSON COLGAN Primary Examiner Art Unit 1784 /LAUREN R COLGAN/Primary Examiner, Art Unit 1784
Read full office action

Prosecution Timeline

Mar 02, 2023
Application Filed
Aug 11, 2025
Non-Final Rejection — §102, §103, §112
Nov 11, 2025
Response Filed
Jan 14, 2026
Final Rejection — §102, §103, §112
Apr 09, 2026
Request for Continued Examination
Apr 09, 2026
Response after Non-Final Action
Apr 10, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600666
GLASS ARTICLE HAVING AN ANTI-REFLECTIVE COATING
2y 5m to grant Granted Apr 14, 2026
Patent 12594744
INTERLAYER FILM FOR LAMINATED GLASS, AND LAMINATED GLASS
2y 5m to grant Granted Apr 07, 2026
Patent 12591274
GLASS SUBSTRATE FOR FLEXIBLE DISPLAY AND DISPLAY DEVICE INCLUDING THE SAME
2y 5m to grant Granted Mar 31, 2026
Patent 12585046
Heatable Windshield
2y 5m to grant Granted Mar 24, 2026
Patent 12578295
ELECTRODE HAVING CARBON LAYER WITH SP3/SP2 BONDING
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
75%
With Interview (+5.1%)
2y 7m
Median Time to Grant
Moderate
PTA Risk
Based on 905 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month